Lorenz Matthias W, Karbstein Peter, Markus Hugh S, Sitzer Matthias
Department of Neurology, J.W. Goethe-University, Frankfurt am Main, Germany.
Stroke. 2007 Jun;38(6):1774-9. doi: 10.1161/STROKEAHA.106.476135. Epub 2007 Apr 19.
It is unclear whether elevated serum C-reactive protein (CRP) is causal to the initiation and progression of atherosclerosis. We undertook a prospective longitudinal cohort study to address this question.
In a population-based sample of 3122 subjects, we measured carotid intima media thickness (IMT) at baseline and after 3 years and surveyed clinical events. Associations between baseline high-sensitivity CRP (hs-CRP) and baseline IMT, and IMT progression were determined before and after controlling for vascular risk factors. The relationship between baseline IMT and clinical events during follow up was determined.
All vascular risk factors were significantly associated with hs-CRP (P<0.001). Hs-CRP was significantly associated with baseline IMT in all carotid segments (P<0.001), but this association was no longer significant after controlling for age, gender, and cardiovascular risk factors. Hs-CRP was not related to individual IMT progression. Interactions between hs-CRP and body mass index, HbA1c, or blood pressure showed no association with IMT progression. Baseline hs-CRP was related to the risk of clinical events (myocardial infarction or stroke or death, hazard ratio of 1.22 per mg/L hs-CRP increase, 95% CI: 1.07 to 1.39, P=0.004, adjusted for age and gender), but this association was not significant after controlling for age, gender, and cardiovascular risk factors (1.59, 95% CI: 0.96 to 2.64, P=0.072).
Our results suggest that hs-CRP is not an independent causal factor for the initiation and progression of early atherosclerotic changes of the carotid arteries. Univariate associations between hs-CRP and IMT were largely explained by confounding by age, gender, and cardiovascular risk factors.
血清C反应蛋白(CRP)升高是否是动脉粥样硬化发生和进展的病因尚不清楚。我们开展了一项前瞻性纵向队列研究来解决这个问题。
在一个基于人群的3122名受试者样本中,我们在基线时和3年后测量了颈动脉内膜中层厚度(IMT),并调查了临床事件。在控制血管危险因素之前和之后,确定基线高敏CRP(hs-CRP)与基线IMT以及IMT进展之间的关联。确定了基线IMT与随访期间临床事件之间的关系。
所有血管危险因素均与hs-CRP显著相关(P<0.001)。Hs-CRP与所有颈动脉节段的基线IMT显著相关(P<0.001),但在控制年龄、性别和心血管危险因素后,这种关联不再显著。Hs-CRP与个体IMT进展无关。Hs-CRP与体重指数、糖化血红蛋白或血压之间的相互作用与IMT进展无关。基线hs-CRP与临床事件风险相关(心肌梗死或中风或死亡,hs-CRP每升高1mg/L的风险比为1.22,95%CI:1.07至1.39,P=0.004,按年龄和性别调整),但在控制年龄、性别和心血管危险因素后,这种关联不显著(1.59,95%CI:0.96至2.64,P=0.072)。
我们的结果表明,hs-CRP不是颈动脉早期动脉粥样硬化改变发生和进展的独立病因。Hs-CRP与IMT之间的单变量关联在很大程度上是由年龄、性别和心血管危险因素的混杂因素所解释的。